Zimmer Biomet Holdings (NYSE:ZBH) is a global leader in orthopedics reconstructive products. The company holds the top spot in the worldwide hips and knees replacement markets. Over the past few ...

Zimmer Biomet CPT ® Hip System implants may put patients at an increased risk of suffering a broken thigh bone near the device. In some cases, patients may even need to undergo corrective surgery. At ...

Tips将繁杂的财务数据化繁为简，转换为可操作的投资见解。 Zimmer Biomet Holdings Inc是一家肌肉骨骼保健公司。该公司从事骨科重建产品的设计、制造和营销；运动医学、生物制品、四肢和创伤产品；脊柱、颅颌面和胸部（CMFT）产品；牙科植入物和相关的外科产品。

Robbie Marcus, an analyst from J.P. Morgan, maintained the Buy rating on Zimmer Biomet Holdings (ZBH – Research Report). The associated price target is $128.00. Discover top-rated stocks from ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Warsaw, Indiana-based Zimmer Biomet Holdings, Inc. (ZBH) designs, manufactures and markets effective and innovative solutions that support orthopedic surgeons and clinicians in restoring mobility ...

Zimmer Biomet Holdings (ZBH) is expanding its product portfolio and improving cash flow, positioning it for long-term profitability and financial health. ZBH is undervalued compared to peers ...

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our ...